Introduction
15100. Anti double-stranded DNA (anti-dsDNA) and anti-glomerular basement membrane antibodies were The aetiology of antineutrophil cytoplasmic autoantinegative. Complement levels were normal. Chest X-ray body (ANCA)-associated vasculitis is unknown, showed bilateral alveolar shadowing consistent with although environmental triggers have been proposed. pulmonary haemorrhage ( Figure 1 ). Corrected gas There are a few published reports of an association transfer ( KCO) was elevated at 3.67 (173% greater between treatment with the antithyroid drug propylthithan predicted). An ultrasound scan of the kidneys ouracil and the occurrence of ANCA positivity and was normal. Renal biopsy showed focal segmental ANCA-associated vasculitis. We discuss a patient necrotizing lesions associated with extracapillary proliftreated with propylthiouracil who developed an eration typical of a vasculitic glomerulonephritis ANCA-positive vasculitis with glomerulonephritis and ( Figure 2 ). Staining for immunoglobulin and complepulmonary haemorrhage. ment components was negative. She was treated with 6×2.5 l plasma exchanges, pulse methyl prednisolone (500 mg/day for 3 days)
Case report
followed by oral prednisolone (60 mg/day), and oral cyclophosphamide (2 mg/kg/day). Propylthiouracil In 1993 a previously healthy 30-year-old woman was was discontinued. She made an uncomplicated clinical diagnosed as having autoimmune thyrotoxicosis. She recovery. Chest X-ray, urinalysis, CRP, and ESR was treated with carbimazole for 5 months, then con-returned to normal. Her KCO is now 55% of the verted to propylthiouracil as she wished to conceive. predicted normal. She remains strongly pANCA positIn November 1996 she was admitted with a 4-week ive with a titre of 15400. ANA has become negative. history of deafness, tinnitus, and general malaise. In the week prior to admission she had developed progressive dyspnoea and frank haemoptysis. On clinical examination she was tachypnoeic, pale and apyrexial. Heart rate was 92/min and blood pressure 110/80 mmHg. On chest auscultation there were bilateral coarse basal crackles to both mid-zones. There were no other abnormal clinical findings.
Investigation results included haemoglobin 4.8 g/dl, white cell count 4.5×109/l with a normal differential and platelets 349×106/l. Serum urea was 10.7 mmol/l and creatinine 68 mmol/l. Creatinine clearance was reduced at 51 ml/min. Urine analysis showed blood (+++) and protein (+++) and albuminuria was quantified as 0.008 g/l. Erythrocyte sedimentation rate ( ESR) was 51 mm/h and C-reactive protein (CRP) 156 mg/l (normal range <10). ANCA was positive with a perinuclear pattern at a titre of 15400 with an anti-myeloperoxidase (anti-MPO) specificity (antiproteinase 3 [anti-PR3] was not detectable), anti- shadowing consistent with pulmonary haemorrhage.
Hypersensitivity vasculitis associated with propylthiouracil may affect any organ with skin lesions being the most common [11] . Our patient is extremely unusual in that she presented with pulmonary haemorrhage and renal vasculitis. To our knowledge there have only been three other reports of pulmonary haemorrhage associated with propylthiouracil-induced ANCA positive vasculitis [10, 12, 13] , of which only one had renal involvement [10] . Treatment included withdrawal of propylthiouracil in all the patients, one patient also received treatment with corticosteroids improved following treatment.
Vasculitis has also been reported with the use of carbimazole and methimazole. D'Cruz [10] reported a Treatment with cyclophosphamide was stopped after patient who, a month after discontinuation of carbima-5 months and changed to azathioprine 100 mg, she zole, developed a Wegener's type illness. Treatment continues on 10 mg of prednisolone as maintenance included plasma exchange, cyclophosphamide, and therapy. She remains biochemically euthyroid off prednisolone. Of the three patients reported by treatment.
Tanemoto, one was receiving both propylthiouracil and methimazole, the causative drug could not be identified and both were discontinued, with resolution Discussion of symptoms [6 ] . At the molecular level, the three different antiVasculitis associated with anti-thyroid medication thyroid drugs are all based on a heterocyclic compound containing a thiomide group, yet despite these strucThe overall incidence of important side-effects of protural similarities, there does not appear to be any cross pylthiouracil varies from 1-5%. Rare but serious comsensitivity. In two of the patients reported by plications include agranulocytosis, hepatotoxicity, and drug induced hypersensitivity.
Tanemoto, methimazole was substituted for propylthi-A clinical association between ANCA positivity and ouracil and vice versa to control the hyperthyroidism clinical symptoms of drug induced hypersensitivity without recurrence of the symptoms induced by the associated with propylthiouracil was initially reported other drug [6 ] . Dolman also substituted methimazole by Dolman et al. in six female patients [1] . These in three of his patients with no untoward effects [14] . patients developed ANCA against human neutrophil However in two reports of vasculitis induced by propylelastase and either proteinase 3 or myeloperoxidase thiouracil, one of which was non-renal, the patients (three patients had all three autoantibodies). All had had previously demonstrated carbimazole intolerance normal renal function though three had microscopic (developing a carbimazole rash) [10, 15] . This suggests haematuria but no proteinuria. Two patients had skin that substitution of these drugs should be undertaken biopsies suggesting vasculitis and one had a nasal with caution. biopsy suggesting Wegener's granulomatosis but there Withdrawal of the propylthiouracil does not always was no granuloma. Only one patient was treated with result in a fall in titre or disappearance of circulating immunosuppressive therapy (cyclophosphamide and ANCA. Our patient has remained ANCA positive prednisolone), the others responded to withdrawal of seven months after withdrawal of the propylthiouracil the propylthiouracil.
at high titre (pANCA 1:400). It is interesting to note There are 14 reports of ANCA associated pauci-that patients with the idiopathic disease who remain immune glomerulonephritis associated with propylthi-ANCA positive are at increased risk of relapse [16, 17] . ouracil, of which two occurred in children [2] [3] [4] [5] [6] [7] [8] [9] (see Despite propylthiouracil withdrawal these patients may Table 1 ). Three of these patients were treated with still be at risk of disease recrudescence and should prednisolone and cyclophosphamide, not all improved remain under long term follow-up. with one of the treated children progressing to endIdiosyncratic reactions associated with propylthiourstage renal failure [4, 10] . One was treated with cycloacil such as agranulocytosis or vasculitis usually occurs phosphamide alone [2] . Seven patients were treated within weeks of the start of treatment although reports with prednisolone alone, one deteriorated with a furoccuring several years after commencement of treatther decline in renal function [6] [7] [8] . Two patients ment are reported. In the patients reported duration showed improvement following discontinuation of of propylthiouracil treatment ranged from 1 week to their propylthiouracil, neither received immunosuppressive treatment [6 ] . 84 months. 
Possible pathogenic mechanisms
It is unclear whether the altered state of self tolerance present in these patients contributes to the It has been suggested that myeloperoxidase, which is development of ANCA or whether there is an interinvolved in the formation of reactive metabolites from action between myeloperoxidase and propylthiouracil, propylthiouracil, may bind covalently to one of these resulting in an immunogenic compound. At present no metabolites [18] . The myeloperoxidase may be modi-good animal model of ANCA associated systemic fied, forming an immunogenic conjugate with the meta-vasculitis exists. Thyrotoxic cats were treated with bolite acting as a hapten. When studied the ANCA propylthiouracil, two of five of these cats developed a binding site did not involve the propylthiouracil meta-lupus like syndrome with ANCA [21] . The developbolites, though this does not preclude the drug metament of these antibodies supports the concept that bolites acting as a hapten. It is possible that the metabolites of propylthiouracil binding to myeloperoxmechanism suggested for the development of ANCA idase are capable of inducing antibody production may also occur in idiopathic ANCA associated vasculand that these antibodies were involved in the pathoitis. However many of the patients reported had several genesis of the syndrome. Unfortunately, when the ANCA specificities detected (anti-PR3, anti-MPO and experiments were repeated the cats did not develop anti-leucocyte elastase) which is uncommon in the vasculitis, though this may have been due to a change idiopathic disease and may therefore represent a in diet rendering these cats less susceptible to different pathogenic mechanism for the development immune disease. of autoantibody [19] . The mechanism behind ANCA The association between propylthiouracil and development is further complicated by the fact that ANCA associated vasculitis is an important, although anti-neutrophil antibodies are not uncommonly seen rare side-effect of this widely used drug. As in our in patients with Graves' disease, this may be a result patient, it can cause life-threatening pulmonary-renal of the similarities between thyroid peroxidase and syndrome which has a high morbidity and mortality. myeloperoxidase. Development of ANCA may occur
Occurrence of symptoms of vasculitis should necessitwith other drugs including hydralazine and penicillamate immediate withdrawal of the drug. The need for ine though their occurrence with these drugs is strongly treatment with immunosuppressive therapy is less clear, HLA-DR3 linked [20] . The HLA status of patients although it is probable that aggressive disease should developing ANCA associated with propylthiouracil has not been studied.
be treated with immunosuppressive regimes.
